Sign In
News Digest /
Income Statements
Income Statements
08:06am, Thursday, May 15, 2025
Company Overview: Invivyd, Inc. (NASDAQ: IVVD) is focused on developing monoclonal antibodies (mAbs) for serious viral infectious diseases, primarily COVID-19 through its product PEMGARDA™ (pemivibart).
Key Financial Highlights:
Revenue: Product revenue for Q1 2025 reached $11.3 million, marking...
08:05am, Thursday, May 15, 2025
Venus Concept Inc. (NASDAQ: VERO) Q1 2025 Earnings Overview
Key Financial Metrics:
Total Revenue: $13.6 million (down 21.9% from $17.5 million in Q1 2024)
Net Loss: $(12.4) million (increased from $(9.8) million in Q1 2024)
Cash and Cash Equivalents: $3.2 million (decreased from $4.3 million at ...
08:05am, Thursday, May 15, 2025
**Zenas BioPharma, Inc. (NASDAQ: ZBIO) Overview**
Financial Highlights (3 months ended March 31, 2025):
Total Revenue: $10.0 million (up from $0 in the same period last year)
Net Loss: $33.6 million (compared to $27.8 million loss in Q1 2024)
Operating Expenses: $47.3 million (compared to $27.6 ...
08:04am, Thursday, May 15, 2025
DT Cloud Acquisition Corporation (NASDAQ: DYCQ) is a blank check company incorporated in the Cayman Islands. As of March 31, 2025, the company has not commenced any operations outside its initial public offering (IPO) and the search for potential business combinations.
Key aspects from the latest...
08:04am, Thursday, May 15, 2025
FitLife Brands, Inc. (OTCMKTS: FTLF) has released its quarterly report for Q1 2025. Here are the key points and statistics from the income statement and operations:
Revenue: Decreased 4% year-over-year to $15,936, compared to $16,549 in Q1 2024.
Cost of Goods Sold: Decreased 2% to $9,062 from $9...
08:04am, Thursday, May 15, 2025
Incannex Healthcare Inc. (NASDAQ: IXHL) has released its latest quarterly financial report for the period ending March 31, 2025. Here are some crucial insights into its income statement and current company status:
Key Financial Highlights:
Net Loss: $15.3 million for the nine months ending March...
08:03am, Thursday, May 15, 2025
Company Overview
Precision BioSciences, Inc. (NASDAQ: DTIL) is a clinical stage gene editing company that is focused on developing transformative in vivo therapies using its proprietary ARCUS genome editing platform. The company is currently advancing several gene editing programs targeting rare ...
08:02am, Thursday, May 15, 2025
Abeona Therapeutics Inc. (NASDAQ: ABEO) has reported its financial results for the quarter ended March 31, 2025, with significant developments impacting its financial health and operational outlook.
Key Highlights:
FDA Approval: The company received FDA approval for ZEVASKYN™, the first autologo...
08:02am, Thursday, May 15, 2025
Company Overview
Pyxis Oncology, Inc. (NASDAQ: PYXS) is a Delaware-based clinical stage oncology company focused on developing novel therapeutics for treating solid tumors, particularly head and neck squamous cell carcinoma (HNSCC).
Recent Financial Performance
Net Loss: $21.2 million for Q1 202...
08:02am, Thursday, May 15, 2025
Palvella Therapeutics, Inc. (OTCMKTS: PIRS) has released its quarterly financial results for the period ending March 31, 2025. The firm has undergone significant changes and is focusing on developing therapies for rare genetic skin diseases.
Key Highlights:
Net loss for Q1 2025: $8.2 million, up...
08:01am, Thursday, May 15, 2025
Company Overview
Galectin Therapeutics Inc. (NASDAQ: GALT) is a clinical stage biopharmaceutical company focused on developing therapies for fibrotic diseases and cancer using its expertise in galectin research. The company's lead product candidate, belapectin, is being studied for treatment in p...
08:01am, Thursday, May 15, 2025
Aclarion, Inc. (NASDAQ: ACON)
Aclarion, Inc. has reported its financial results for the first quarter of 2025, revealing both positive growth and challenges. The company specializes in healthcare technology, particularly leveraging magnetic resonance spectroscopy to enhance clinical treatments.
K...
08:00am, Thursday, May 15, 2025
TriSalus Life Sciences, Inc. (NASDAQ: MTAC) is navigating significant developments and challenges as it reports its financial performance for the first quarter of 2025. The company has undergone a recent merger and is dedicated to oncology-focused medical technologies, particularly for solid tumo...
07:04am, Thursday, May 15, 2025
Journey Medical Corporation (NASDAQ: DERM) has released its quarterly financial results for Q1 2025, which have brought both optimistic and challenging aspects to light.
Positive Aspects:
Revenue for Q1 2025 was $13.1 million, a slight increase from $13.0 million in Q1 2024, indicating stable sa...
07:03am, Thursday, May 15, 2025
Nuvera Communications, Inc. (PINK: NUVR)
In the first quarter of 2025, Nuvera Communications, Inc. reported notable changes in its financial performance compared to the same period in 2024. The total operating revenues increased by approximately 5.52% to $17.88 million, driven primarily by growth...
07:03am, Thursday, May 15, 2025
Black Spade Acquisition II Co (NASDAQ: BSIIU) has recently released its quarterly financial report for the period ended March 31, 2025, revealing both significant operational insights and financial statistics.
Key Financial Highlights:
Net income stood at $10,378, bolstered by interest income fr...
07:02am, Thursday, May 15, 2025
Aura Biosciences, Inc. (NASDAQ: AURA) declared a net loss of $27.5 million during Q1 2025, compared to a loss of $19.7 million in Q1 2024. Its operations are heavily dependent on a clinical-stage product, bel-sar, which has not yet reached the market.
Key Points and Statistics:
Income Statement ...
07:02am, Thursday, May 15, 2025
GBT Technologies Inc. (PINK: GTCH)
Overview:
GBT Technologies Inc. engages in the development of Internet of Things (IoT) and artificial intelligence (AI) enabled technologies. The company's activities include a focus on wireless mesh networks and various health monitoring devices.
Recent Develop...
07:02am, Thursday, May 15, 2025
Community Bancorp. (OTCMKTS: CMTV) - Q1 2025 Financial Overview
Community Bancorp. reported its quarterly results for the period ending March 31, 2025, showing several key metrics and trends:
Net Income: Increased to $3.5 million, a 25% rise from $2.8 million in Q1 2024.
EPS: Earnings per share ...
07:01am, Thursday, May 15, 2025
Company OverviewVystar Corporation (PINK: VYST) focuses on innovative air purification technology and natural rubber latex products. The company has been navigating through ongoing challenges related to its financial performance, particularly reflected in its latest income statement for the quart...
07:01am, Thursday, May 15, 2025
Company Overview:
Cosmos Group Holdings Inc. (PINK: COSG) is a Nevada-based holding company that operates mainly through its subsidiaries in Hong Kong and Singapore. The company is engaged in the arts and collectibles market, utilizing blockchain technology to address issues of provenance, authen...
07:00am, Thursday, May 15, 2025
DSwiss, Inc. (PINK: DQWS) has recently reported its financial results for the quarter ended March 31, 2025. The company operates in the biotech-nutraceutical, beauty supplies, and medical consumables sectors with a focus on high-quality products.
Key Financial Highlights:
Revenue: $1,001,186, up...
07:00am, Thursday, May 15, 2025
Bubblr, Inc. (PINK: BBLR) investors should take note of the company's recent financial performance as detailed in their Q1 2025 earnings report. The company is currently navigating various challenges and opportunities as it works to launch new AI-driven products.
Key Financial Highlights:
Revenu...
06:12pm, Wednesday, May 14, 2025
Company Overview
Red Cat Holdings, Inc. (NASDAQ: RCAT) is a Nevada corporation focused on drone technology, providing integrated robotic hardware and software solutions. The company has seen significant developments, particularly with its expansion into military applications and its recent financ...
06:11pm, Wednesday, May 14, 2025
Armlogi Holding Corp. (NASDAQ: BTOC) - Q1 FY2025 Review
Recent Developments:
Armlogi experienced significant revenue growth in Q1 FY2025, reflecting a larger volume of transactions across its logistics services.
The logistics sector is increasingly expanding due to rising e-commerce, especially ...
06:11pm, Wednesday, May 14, 2025
Talphera, Inc. (NASDAQ: ACRX) has recently published its Q1 2025 results, reflecting key financial aspects of the company's operations.
Positive Aspects:
Increasing Revenue: The company generated $27K in revenue, up from $0 in Q1 2024.
Improved Net Loss: Net loss decreased to $2.6 million from $...
06:10pm, Wednesday, May 14, 2025
Company Overview
Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) is a clinical-stage biopharmaceutical company focused on developing cancer treatments addressing dysregulated gene expression. The company has not yet generated any revenue from product sales and has consistently experienced operating...
06:10pm, Wednesday, May 14, 2025
Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) has recently released its quarterly financial results for the period ending March 31, 2025. The company's focus remains on the development of innovative drug formulations aimed at addressing serious medical conditions, primarily through the reformulatio...
06:10pm, Wednesday, May 14, 2025
GlycoMimetics, Inc. (NASDAQ: GLYC) recently released its quarterly financial results for the period ending March 31, 2025.
After conducting a strategic review prompted by disappointing clinical trial results and subsequent discussions with the FDA, GlycoMimetics has decided to merge with Crescent...
06:09pm, Wednesday, May 14, 2025
Blaize Holdings, Inc. (NASDAQ: BZAI) is navigating a complex financial environment following its recent merger with BurTech Acquisition Corp. as part of a reverse recapitalization on January 13, 2025. The company's activities focus on artificial intelligence-driven edge computing solutions. Below...
06:09pm, Wednesday, May 14, 2025
Bunker Hill Mining Corp. (PINK: BHLL) has released its quarterly report for the period ending March 31, 2025. The company showcases a mixed financial performance as it grapples with restructuring efforts and ongoing operational challenges.
Key Highlights from the Income Statement:
Total Revenue:...
06:09pm, Wednesday, May 14, 2025
Stardust Power Inc. (NASDAQ: GPAC) has recently released its quarterly financial results for the period ended March 31, 2025. Here’s a concise overview of the key aspects affecting the company.
Positive Aspects of the Income Statement:
Cash Position: As of March 31, 2025, the company reported ca...
06:08pm, Wednesday, May 14, 2025
Two Hands Corporation (PINK: TWOH) - Q1 2025 Overview
Two Hands Corporation has posted its quarterly financial results for the period ending March 31, 2025. The company, having pivoted from its previous business endeavors, is now focused on grocery delivery systems via continuous operational eval...
06:07pm, Wednesday, May 14, 2025
Company Overview: Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) is a clinical-stage biotechnology company dedicated to developing innovative therapies for immune-mediated and metabolic diseases. As of March 31, 2025, the company reported a net loss of approximately $9.93 million.
Financial Summary:
...
06:07pm, Wednesday, May 14, 2025
bluebird bio, Inc. (NASDAQ: BLUE) has reported its quarterly results for the period ending March 31, 2025. The company is facing significant financial challenges while attempting to commercialize its gene therapies, ZYNTEGLO, SKYSONA, and LYFGENIA.
Key Positive Highlights:
Revenue Growth: Produc...
06:06pm, Wednesday, May 14, 2025
NATURAL ALTERNATIVES INTERNATIONAL INC. (NASDAQ: NAII) has reported its financial results for the third quarter of 2025, ending March 31, 2025. Below are some key insights from the income statement and overall company performance.
Income Statement Highlights:
Net Sales: Increased to $28.8 millio...
06:06pm, Wednesday, May 14, 2025
Horizon Kinetics Holding Corporation (PINK: SLGD) reported its financial results for the first quarter ending March 31, 2025, showcasing a mix of positive and negative aspects in its income statement.
Key Highlights:
Total Revenue: $19.80 million, a 63.23% increase from $12.13 million year-over-...
06:05pm, Wednesday, May 14, 2025
Glucotrack, Inc. (NASDAQ: GCTK) is a medical device company currently developing an implantable continuous blood glucose monitor, aiming to aid patients with Type 1 diabetes and insulin-dependent Type 2 diabetes. The company has made notable progress in its research and is engaged in several fina...
06:05pm, Wednesday, May 14, 2025
Knightscope, Inc. (NASDAQ: KSCP) is a public safety innovator focused on designing and deploying Autonomous Security Robots (ASRs) and Emergency Communication Devices (ECDs) aimed at enhancing security and emergency services. This review analyzes their recent financial performance, revealing both...
06:05pm, Wednesday, May 14, 2025
Company Overview
Arbutus Biopharma Corporation (NASDAQ: ABUS) is a clinical-stage biopharmaceutical company focused on developing therapies for chronic hepatitis B (cHBV). They have two lead candidates: imdusiran (AB-729), an RNAi therapeutic, and AB-101, a PD-L1 inhibitor. The company is activel...
